Nonlegal, judicial, and statutory courses of action are available to patient surrogates and physicians who cannot agree on withdrawal of life-sustaining treatment.
When evaluating the developments and complications of a marginally viable premature infant, physicians and parents must work together to decide on treatment that is in the infant’s best interest.
This article asks whether the benefits of neuroelectronic devices that restore function outweigh their risks to the individual and society and whether we should move beyond therapy to enhance our capabilities by the use of such devices?
Brain-computer interfaces raise many ethical questions. The brain is inviolate no more, and that implies a challenge for medical ethics as neuroscientists and surgeons attempt to restore and enhance brain function.
Physicians should fully understand the ethical principles and professional standards involved in making decisions for the treatment of impaired newborns.
Physicians should seriously weigh the benefits and risks involved prior to discussing the possibility of genetic testing with a patient or referring them to a genetic counselor.